The concentration of CD95L (500 ng/ml) applied on the B-CLL cells eliminated 100% of the EBV-transformed lymphoid (SKW 6.4, Dab-1) and the T leukemia (Jurkat, CEM) cell lines (data not shown). This evidence concerns the gene FASLG and leukemia.